Skip to main content
. Author manuscript; available in PMC: 2018 Apr 13.
Published in final edited form as: Obesity (Silver Spring). 2015 Dec 6;24(1):79–86. doi: 10.1002/oby.21331

Table 1.

Baseline Participant Characteristics*

Variable Insulin Resistant Insulin Sensitive
Low-Fat (n=15) Low-Carbohydrate (n=16) Low-Fat (n=16) Low-Carbohydrate (n=14)
Percent women 60% 63% 63% 64%

Age (years) 44 ± 5 42 ± 6 41 ± 6 43 ± 7

Education (years) 16.0 ± 2.0 16.4 ± 1.8 15.9 ± 3.3 16.1 ± 1.9

Percent non-white 13% 13% 25% 0%

Anthropometrics

 BMI (kg/m2) 35.0 ± 2.4 34.2 ± 3.8 32.6 ± 2.9 31.2 ± 1.9

 Waist circumference 1.1 ± 0.1 1.1 ± 0.1 1.0 ± 0.1 1.1 ± 0.1

Cardiovascular disease risk factors

 LDL-C (mg/dL) 118 ± 20 108 ± 19 111 ± 30 113 ± 34

 HDL-C (mg/dL) 43 ± 10 44 ± 13 51 ±17 49 ± 14

 Triglycerides (mg/dL) 146 ±58 156 ± 68 117 ± 59 136 ± 99

 Fasting insulin (μU/mL) 21 ± 5.9 27.7 ± 11.4 13.4 ± 3.1 13.4 ± 3.1

 Fasting glucose (mg/dL) 100.9 ± 11.2 102.5 ±11.8 102.7 ± 11.6 99.1 ± 7.5

 Insulin AUC (μU × min/ml) 130.9 ± 54 144 ± 49.5 65 ± 19 58 ± 18.4

Blood Pressure (mm Hg)

 Systolic 122 ± 12 125 ± 10 116 ± 13 117 ±12

 Diastolic 81 ± 8 83 ± 8 77 ± 9 78 ± 7

Percent Metabolic Syndrome 46.67% 56.25% 18.75% 35.71%

Physical activity (Kcal/kg/day) 33.2 ± 0.9 32.7 ± 1.2 34.0 ± 1.7 33.6 ± 1.4

Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol

*

Data are expressed as mean ± SD unless otherwise indicated